Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S., F.C.P.S ( Gastroenterologist )
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Gastroenterologist
MBBS, MRCP (UK), FCPS (Gastroenterology), M.D (USA), Gastroenterology SCE (UK) , European Board of Gastroenterology and Hepatology (EBGH)
Gastroenterologist
MBBS, MRCP (UK), FCPS (Gastroenterology), M.D (USA), Gastroenterology SCE (UK) , European Board of Gastroenterology and Hepatology (EBGH)
Cardiologist
M.B.B.S., MMSc (Cardiology), Dip Echo, MRCP (UK), Cert. in Diabetes
Family Physician
M.B.B.S, M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
MBBS, MD Internal Medicine, Certificate of Myocardial Infarction
Internal Medicine Specialist
MBBS, MD Internal Medicine, Certificate of Myocardial Infarction
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology)
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology)
Cardiologist
MBBS, Diplomat Endocrinology , MSc Diabetes (UK), MSc (Cardiology)
Cardiologist
MBBS, Diplomat Endocrinology , MSc Diabetes (UK), MSc (Cardiology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures